References
- Rosenberg MJ, Long SC. Oral contraceptives and cycle control: a critical review of the literature. Adv Contracept 1992; 8(Suppl 1)35–35
- Rosenberg M, Waugh M. Oral contraceptives and cycle control: are the new progestogens better?. 1994; 415, Med Dial
- Latin American Oral Contraceptive Study Group. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinylestradiol and desogestrel/ethinylestradiol. Contraception 1994; 50: 201–14
- Düsterberg B, Beier S, Schneider WHF, Spona J. Pharmacological features of gestodene in laboratory animals and man. Gestodene, a New Direction in Oral Contraception, M Breckwoldt, B Düsterberg. Parthenon Publishing, CarnforthUK 1988; 13–29
- Brill K, Norpoth T, Schnitker J, Albring M. Clinical experience with a modern low dose oral contraceptive in almost 100 000 users. Contraception 1991; 43: 101–10
- Yuzpe AA. Triphasic levonorgestrel: its role in oral contraception. Gynecol Endocrinol 1995; 9(Suppl 2)29–29
- Brill K, Müller C, Schnitker J, Albring M. The influence of different low-dose oral contraceptives on intermenstrual bleeding. Adv Contracept 1991; 7(Suppl 2)51–51
- Moos RH. The development of a menstrual distress questionnaire. Psychosom Med 1968; 30: 853–67
- Markum R. Assessment of the reliability of and the effect of neutral instructions on the symptom ratings on the Moos Menstrual Distress Questionnaire. Psychosom Med 1976; 38: 163–72
- Gruba GH, Rohrbaugh M. MMPI correlates of menstrual distress. Psychosom Med 1975; 37: 265–73
- Brooks J, Ruble D, Clark A. College women's attitudes and expectations concerning menstrual-related changes. Psychosom Med 1977; 39: 288–98
- Paige KE. Effects of oral contraceptives on affective fluctuations associated with the menstrual cycle. Psychosom Med 1971; 33: 515–37
- Lacante P. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gynecol Endocrinol 1996; 10(Suppl 2)33–33
- Rabe T, Maletz-Kehry W, Leppien G, et al. Clinical update on triphasic gestodene. Gynecol Endocrinol 1993; 7(Suppl)25–25
- Andrade RP. Clinical comparison of a triphasic gestodene preparation and a monophasic desogestrel preparation. Gynecol Endocrinol 1993; 7(Suppl)33–33
- Back DJ, Grimmer SFM, Shenoy N, et al. Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel. Contraception 1987; 35: 619–26